Completed OBSERVATIONAL NCT06642467
BGEM Use as Blood Glucose Prediction Model in T2DM Population of Indonesia
Sponsor: Actxa
Conditions
Diabete Type 2
Interventions
BGEM
Updated 1 time since 2024 Last updated: Oct 11, 2024 Started: Jul 30, 2024 Primary completion: Oct 5, 2024 Completion: Oct 5, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06642467, this observational or N/A phase trial focuses on Diabete Type 2 and remains completed. Sponsored by Actxa, it has been updated 1 time since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Actxa
- Krida Wacana Christian University
- Lif
Data source: Krida Wacana Christian University
For direct contact, visit the study record on ClinicalTrials.gov .